¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Ç¥"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
epidermolysis
Ç¥Çǹڸ®(Áõ)
epidermolytic acanthoma
Ç¥Çǹڸ®°¡½Ã¼¼Æ÷Á¾, Ç¥Çǹڸ®±Ø¼¼Æ÷Á¾
epidermolytic hyperkeratosis
Ç¥Çǹڸ®°ú´Ù°¢ÈÁõ
epidermolytic palmoplantar keratoderma
Ç¥Çǹڸ®¼Õ¹ß¹Ù´Ú°¢ÁúÇǺÎÁõ
epidermabrasion
Ç¥ÇǹÚÇÇ(¼ú), Ç¥Çǹþ±è(¼ú)
epidermal inclusion cyst
Ç¥ÇǺÀÀÔ³¶, Ç¥ÇÇÆ÷ÇÔ³¶
epidermal appendage
Ç¥ÇǺμӱâ
Epidermophyton
Ç¥ÇÇ»ç»ó±Õ(¼Ó)
epidermal growth factor
Ç¥ÇǼºÀåÀÎÀÚ
epidermal cell
Ç¥ÇǼ¼Æ÷
tegmental cell
Ç¥ÇǼ¼Æ÷
epidermitis
Ç¥ÇÇ¿°
epidermolytic toxin
Ç¥ÇÇ¿ëÇØµ¶¼Ò
epidermolysin
Ç¥ÇÇ¿ëÇØ¼Ò, Å»¶ô¼Ò
epidermal ridge
Ç¥ÇÇÀ¶±â
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
mimic
1. Ç¥Á¤- 2. ¸ðÀÇ-
molecular marker
ºÐÀÚÇ¥ÁöÀÚ
monomeric
1. ´Ü·®Ã¼- 2. ´ÜÀÏÀ¯ÀüÀÚÇ¥Çö-
mounting
1. Ç¥º»Á¦ÀÛ 2. ºÀÀÔ, ¸¶¿îÆÃ
mucoepidermoid
Á¡¸·Ç¥ÇǸð¾ç-
multitarget model
´ÙÇ¥Àû¸ðµ¨
multitarget multihit model
´ÙÇ¥Àû´ÙÀûÁ߸ðµ¨
multitarget single hit model
´ÙÇ¥Àû´ÜÀÏÀûÁ߸ðµ¨
myasthenic facies
±Ù¹«·ÂÁõÇ¥Á¤
manifestation
¼Ò°ß, Ç¥Çö, Ç¥½Ã
manual expression
1. ¼ÕÁþÇ¥Çö, ¼Õ³î¸² 2. Á¥Â¥±â
mark
1. Á¡, ¹ÝÁ¡ 2. ÀÚ±¹ 3. Ç¥½Ã, Ç¥Áö
marker
1. Ç¥ÁöÀÚ 2. Ç¥Áö
marking
1. Ç¥Áö 2. À½¿µ
MESH
ÀÇÇÐÁÖÁ¦Ç¥Á¦
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
tagging
Ç¥Áö
marking
Ç¥Áö, À½¿µ
marker
Ç¥Áö, Ç¥ÁöÀÚ
marker rescue
Ç¥Áö±¸Á¶
tracer element
Ç¥Áö¿ø¼Ò
marker gene
Ç¥ÁöÀ¯ÀüÀÚ
labeled antigen
Ç¥ÁöÇ׿ø
labeled antibody
Ç¥ÁöÇ×ü
expressed emotion
Ç¥Ãâ°¨Á¤
lamellar keratoplasty
Ç¥Ãþ°¢¸·À̽Ä
superficial cleavage
Ç¥ÃþºÐÇÒ
lamellar hole
Ç¥Ãþ¿ø°ø, ºÒ¿ÏÀü¿ø°ø
superficial pustular folliculitis
Ç¥ÃþÀÜ°í¸§ÁýÅÐÁý¿°
shave excision
Ç¥ÃþÀýÁ¦
superficial punctate keratitis
Ç¥ÃþÁ¡»ó°¢¸·¿°
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
flash-labeled
¼¶±¤Ç¥Áö-
float
ºÎÇ¥, ºÎ³¶
flowchart
È帧ǥ
fatness index nomogram
ºñ¸¸Áö¼öºÐÆ÷Ç¥
ferritin labeling
Æä¸®Æ¾Ç¥Áö
fetal surface
žÆÇ¥¸é
fluorescence activated cell sorter
Çü±¤Ç¥Áö¼¼Æ÷ºÐ¸®±â
fungus smear
Áø±Õ¹Ù¸¥Ç¥º»
graph
µµÇ¥, ±×¸²
golden standard
Àý´ëÇ¥ÁØ
graph paper
µµÇ¥Áö
lamellar graft
ÃþÆÇÀ̽Ä, Ç¥ÃþÀÌ½ÄÆí
probability graph
È®·üµµÇ¥
variant surface glycoprotein
»óÀÌÇ¥¸é´ç´Ü¹éÁú
hyperplastic epidermolysis bullosa
Áõ½Ä¹°ÁýÇ¥Çǹڸ®Áõ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
quadrature surface coil
±¸Àû Ç¥¸é ÄÚÀÏ
quality standard
ǰÁúÇ¥ÁØ(̡̰̤̰).
radiation survey instrument
¹æ»ç¼±Ç¥º»Á¶»ç±â±¸
radiation,target theory of
¡ÀÇ Ç¥ÀûÀÌ·Ð(¡øöîÜìµÖå)
radioactive iodine labeled human serum albumin
¹æ»ç¼º ¿ä¿ÀµåÇ¥ÁöÀÎÇ÷û(¡ øöãÛìÑúìôè)¾ËºÎ¹Î.
radioepidermitis
¹æ»ç¼±Ç¥ÇÇ¿°(Û¯ÞÒàÊøúù«æú)
radioepidermolysis
¹æ»ç¼±Ç¥Çǹڸ®Áõ(Û¯ÞÒàÊøúÚÎìÆñø)
radiolabeled immunoglobulin therapy
¹æ»ç¼ºÇ¥Áö¸é¿ª±Û·ÎºÒ¸°Ä¡·á
radiolabeling
¹æ»ç¼±Ç¥ÁöÀÇ
random number table
³¼öÇ¥(ËÄËà̰).
random sample
¹«ÀÛÀ§Ç¥º»(ËÎËöËô̰ËÓ), È®·üÇ¥º».
random sampling
¹«ÀÛÀ§Ç¥º»ÃßÃâ(ÊÙ̧̧).
real time display
½Ç½Ã°£ Ç¥½Ã
real-time display
½Ç½Ã°£ Ç¥½Ã (ãùãÁÊà øúãÆ)
recessive dystrophic epidermolysis bullosa
¿¼º ¿µ¾çÀå¾Ö ¼öÆ÷ Ç¥Çǹڸ®Áõ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
superficial keratitis ³ª k. superficialis
Ç¥Àç(¼º) °¢¸·¿°(¡ÊÇØ¯æú)
superficial cellulitis
Ç¥Àç(¼º) ºÀ¼Ò¿° (øúî¤àõÜðáµæú)
glossitis superficialis <³ª>
Ç¥Àç(¼º) ¼³¿°
superficial mycosis
Ç¥Àç(¼º) Áø±ÕÁõ (¡òØÐ¶ñø)
superficial mycosis
Ç¥Àç(¼º) Áø±ÕÁõ (¡òØÐ¶ñø).
superficial mycosis
Ç¥Àç(¼º) Áø±ÕÁõ (¡òØÐ¶ñø).
superficial leiomyoma
Ç¥Àç(¼º) ÆòÇÒ±ÙÁ¾ (¡ÆòȰ±ÙÁ¾).
superficial leiomyoma
Ç¥Àç(¼º) ÆòÇÒ±ÙÁ¾(¡øÁüÁÐÉðþ)
superficial (skin and mucous membrane
Ç¥Àç(ÇǺΠ¹× Á¡¸·)¹Ý»ç.
superficial infection
Ç¥À缺 °¨¿°(øúî¤àõÊïæø).
superficial infection
Ç¥À缺 °¨¿°(øúî¤àõÊïæø).
superficial abscess
Ç¥À缺 ³ó¾ç(¡ÒÛåË), õÀç³ó¾ç(ô¼î¤¡)
superficial abscess
Ç¥À缺 ³ó¾ç, õÀç³ó¾ç.
superficial pustular perifolliculitis
Ç¥À缺 ³óÆ÷¼º ¸ð³¶ÁÖÀ§¿°
tinea superficialis ³ª
Ç¥À缺 ¹é¼±(øúî¤àõ ÛÜàÈ).
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
cuticularization
Ç¥ÇÇÁõ½Ä, Ç¥ÇÇÇü¼º.
cylindrical coordinates
¿ø±âµÕÁÂÇ¥ (¡ñ¨øö).
cyst, epidermoid
Ç¥ÇÇ¾ç ³¶Á¾
cyst,epidermal
Ç¥ÇÇ(øúù«)
cyst,epidermoid
À¯Ç¥ÇÇ(ëºøúù«)
cytokeratin
»çÀÌÅäÄɶóƾ<<Á¶Á÷Çü ÁöÇ¥·Î½áÀÇ>>
data display
µ¥ÀÌÅÍÇ¥½Ã
definitive epidermis
¿Ï¼ºÇ¥ÇÇ
delay, phenotypic
Ç¥ÇöÇü ¹ßÇöÁöü
dental cuticle
Ä¡¸éÇ¥ÇÇ(öÍØüøúù«).
depth resolved surface coil spectroscopy (DRESS)
±íÀÌ ÇØ°á Ç¥¸é ÄÚÀÏ ºÐ±¤¹ý
dermaographism, white
¹é»öÇÇ ºÎÇ¥±âÁõ.
dermatograph
ÇǺÎÇ¥±â(ù«Ý±øöÑÀ), ÇǺι¦È(ù«Ý±ÙÚûþ)
dermatographia = dermographia<³ª>
ÇǺÎÇ¥±â(Áõ), ÇǺι¦ÈÁõ(¡ÙÚûþñø)
dermoepidermal
ÁøÇÇÇ¥ÇÇ(òØù«øúù«)ÀÇ
ÀÌÀü
´ÙÀ½
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
5
ÆäÀÌÁö:
8
ÄÚµå
¿µ¹®
ÇѱÛ
T31.3
Burns involving 30-39£¥ of body surface
½Åüǥ¸éÀÇ 30-39£¥¸¦ Æ÷ÇÔÇÑ È»ó
T31.4
Burns involving 40-49£¥ of body surface
½Åüǥ¸éÀÇ 40-49£¥¸¦ Æ÷ÇÔÇÑ È»ó
T31.5
Burns involving 50-59£¥ of body surface
½Åüǥ¸éÀÇ 50-59£¥¸¦ Æ÷ÇÔÇÑ È»ó
T31.6
Burns involving 60-69£¥ of body surface
½Åüǥ¸éÀÇ 60-69£¥¸¦ Æ÷ÇÔÇÑ È»ó
T31.7
Burns involving 70-79£¥ of body surface
½Åüǥ¸éÀÇ 70-79£¥¸¦ Æ÷ÇÔÇÑ È»ó
ÀÌÀü
´ÙÀ½
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
¼³¸í
landmark
¸ñÇ¥, °æ°èÇ¥, ±âÁØÁ¡
¼·Î ÇØºÎÇÐÀûÀÎ °ü°è¸¦ °¡Áö¸é¼ Áöħ ¶Ç´Â ¾È³», ¼³¸íÀ» Çϱâ À§ÇÑ ÇØºÎÇÐÀû ±¸Á¶. ÇØºÎÇÐÀûÀ¸·Î ±âº»ÀÌ µÇ´Â Ç¥ÁØÀÌ µÇ´Â Á¡.
Langerhans cell
¶û°Ô¸£Çѽº ¼¼Æ÷, Ç¥ÇÇ¼Ó Å« Æ÷½Ä¼¼Æ÷
µ¿ÀǾî=intrae
Langmuir expression in drug-antibody binding
¾à¹°-Ç×ü °áÇÕ¿¡¼ÀÇ ¶û¹¿¸£ Ç¥Çö
language representation
¾ð¾î Ç¥Çö
leptocytosis
Ç¥Àû»ó ÀûÇ÷±¸ Áõ°¡Áõ
light bleaching
±¤ Ç¥¹é
line
¼±, °è, ÁöÇ¥, À¶¼±
¶§¶§·Î ¿©·¯ ÇØºÎÇÐÀû ÁöÇ¥¸¦ ¿¬°áÇÏ´Â °¡»óÀûÀÎ ¼±.
lingua cerebelli formis
´ë³ú Ç¥¸é
male phenotype
³²¼º Ç¥ÇöÇü
manual expression
¿ë¼ö Ç¥Çö, ¿ë¼ö Ç¥Çö¼ú
mark
¹Ý, Ç¥Áö, ±âÈ£
Ç¥¸é, ƯÈ÷ ÇǺΠ¶Ç´Â Á¡¸·»ó¿¡¼ º¼ ¼ö ÀÖ´Â ¹ÝÁ¡, ¿ÀÁ¡ ¶Ç´Â ±× ¿Ü °æ°è°¡ ¶Ñ·ÇÇÑ ºÎºÐ.
marker gene
Ç¥Áö À¯ÀüÀÚ
mean target dose
Æò±Õ Ç¥Àû ¼±·®
misbranded drug
ºÎÁ¤ Ç¥½Ã ¾àǰ
model
¸ðµ¨, º»º¸±â, ¸ðÇü, Ç¥ÁØÇü
Áø´ÜÇÐ ¶Ç´Â ÇØºÎÇÐ ¿¬±¸¿ëÀÇ ¸ðÇü°ú °°ÀÌ ´Ù¸¥ ¹°°ÇÀ» Ç¥ÇöÇÏ´Â °Í Ä¡°úÇп¡¼ÀÇ ÁÖÇü Ç¥º».
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
title
Ç¥Á¦;Á¦¸ñ;Ã¥À̸§;ÀÚ¸·;ŸÀÌÆ²;¸íĪ;Á÷ÇÔ;±Ç¸®;ÀÚ°Ý;¼±¼ö±Ç(a ~ match)
gage
Ç¥ÁØ
yardstick
Ç¥ÁØ
standard garge
Ç¥ÁØ ±Ë°£
subaverage
Ç¥ÁØ ¹Ì´ÞÀÇ
philharmonic pitch
Ç¥ÁØ À½µµ
gauge
Ç¥ÁØ Ä¡¼ö(±Ô°Ý);ÀÚ;°è±â;°ÔÀÌÁö;(·¹ÀÏÀÇ)±Ë°£;(Æò°¡,°Ë»çÀÇ)Ç¥ÁØ;¹æ¹ý;(¿µ±¹¿¡¼´Â º¸Åëgage)Ȧ¼ö ¹üÀ§;(¹Ù¶÷°ú µý ¹è¿¡ ´ëÇÑ)À§Ä¡ °ü°è;broad(narrow) ~ ±¤±Ë(ÇÕ±Ë);take the ~ of ...À» °èÃø(Æò°¡)ÇÏ´Ù
gauge
Ç¥ÁØ Ä¡¼ö; °è·®±â; ÃøÁ¤ÇÏ´Ù
standard deviation
Ç¥ÁØ ÆíÂ÷
nonstandard
Ç¥ÁØ(±âÁØ)¿¡ ¸ÂÁö ¾Ê´Â;(Á¦Ç°,¾ð¾î,¹ßÀ½);Ç¥Áؾ ¾Æ´Ñ
subpar
Ç¥ÁØ(¼öÁØ)
normalizer
Ç¥ÁØ(Á¤»ó)ÈÇÏ´Â °Í(»ç¶÷);Á¤±Ôȱº
standard
Ç¥ÁØ,¸ð¹ü,Ç¥ÁØÀûÀÎ,¸ð¹üÀûÀÎ
norm
Ç¥ÁØ;ÀϹݼöÁØ;³ë¸£¸¶(³ëµ¿±âÁØ·®);Æò±Õ¼ºÀû(ÇзÂ)±Ô¹ü;³ë¸£¸¶
overproof
Ç¥ÁØ·® ÀÌ»óÀ¸·Î ¾ËÄÚ¿ÃÀ» ÇÔÀ¯ÇÑ
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
scareheading
ƯÁ¾ ½Å¹®ÀÇ ÅÁ÷ÇÑ Ç¥Á¦.
schedule
À϶÷Ç¥
scorebook
µæÁ¡Ç¥
scrutiny
Á¤»ç(Á¤»ç); ÅõÇ¥ (Àç)°Ë»ç
seamark
Ç׷ΠǥÁö
set forth
Ãâ¹ßÇÏ´Ù; ¹è¿ÇÏ´Ù; ¹ßÇ¥ÇÏ´Ù
sidehead
ÀÛÀº Ç¥Á¦
sideheading
ÀÛÀº Ç¥Á¦
specimen
°ßº»; Ç¥º»
stamp
¿ìÇ¥
stand for
Âü´Ù; ´ëÇ¥ÇÏ´Ù; ÀÔÈĺ¸ÇÏ´Ù
standard
Ç¥ÁØ,¸ð¹ü,Ç¥ÁØÀûÀÎ,¸ð¹üÀûÀÎ
standardization
Ç¥ÁØÈ
standardize
À» Ç¥ÁØ¿¡ ¸ÂÃß´Ù
state' attorney
ÁÖ´ëÇ¥ÀÇ º¯È£»ç
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
ÀÌÀü
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½